227 related articles for article (PubMed ID: 34057564)
21. Review of uterine fibroids: imaging of typical and atypical features, variants, and mimics with emphasis on workup and FIGO classification.
Awiwi MO; Badawy M; Shaaban AM; Menias CO; Horowitz JM; Soliman M; Jensen CT; Gaballah AH; Ibarra-Rovira JJ; Feldman MK; Wang MX; Liu PS; Elsayes KM
Abdom Radiol (NY); 2022 Jul; 47(7):2468-2485. PubMed ID: 35554629
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic management of uterine fibroid tumors: updated French guidelines.
Marret H; Fritel X; Ouldamer L; Bendifallah S; Brun JL; De Jesus I; Derrien J; Giraudet G; Kahn V; Koskas M; Legendre G; Lucot JP; Niro J; Panel P; Pelage JP; Fernandez H;
Eur J Obstet Gynecol Reprod Biol; 2012 Dec; 165(2):156-64. PubMed ID: 22939241
[TBL] [Abstract][Full Text] [Related]
23. Αdnexal cystic lymphangiomas in patients with massive leiomyomatous uterus: a not so uncommon finding on pelvic MRI.
Bourgioti C; Chatoupis K; Tzavara C; Zafeiropoulou K; Panourgias E; Antoniou A; Moulopoulos LA
Abdom Radiol (NY); 2020 Feb; 45(2):537-546. PubMed ID: 31218386
[TBL] [Abstract][Full Text] [Related]
24. Hysterosalpingography findings of leiomyomas and how they look in artistic eyes: new diagnostic signs.
Ahmadi F; Hosseini F; Javam M; Pahlavan F
Br J Radiol; 2021 May; 94(1121):20200019. PubMed ID: 33502912
[TBL] [Abstract][Full Text] [Related]
25. Uterine fibroids: correlations between MRI appearance and stiffness via magnetic resonance elastography.
Jondal DE; Wang J; Chen J; Gorny KR; Felmlee J; Hesly G; Laughlin-Tommaso S; Stewart EA; Ehman R; Woodrum DA
Abdom Radiol (NY); 2018 Jun; 43(6):1456-1463. PubMed ID: 28952003
[TBL] [Abstract][Full Text] [Related]
26. MED12 exon 2 mutations in histopathological uterine leiomyoma variants.
Mäkinen N; Vahteristo P; Kämpjärvi K; Arola J; Bützow R; Aaltonen LA
Eur J Hum Genet; 2013 Nov; 21(11):1300-3. PubMed ID: 23443020
[TBL] [Abstract][Full Text] [Related]
27. Uterine extension determined by MRI: a useful parameter for differentiating subserosal leiomyomas from ovarian tumors.
Kawaguchi M; Kato H; Noda Y; Furui T; Morishige KI; Hyodo F; Matsuo M
Abdom Radiol (NY); 2022 Mar; 47(3):1142-1149. PubMed ID: 34994842
[TBL] [Abstract][Full Text] [Related]
28. The Impact of Hormonal Replacement Treatment in Postmenopausal Women with Uterine Fibroids: A State-of-the-Art Review of the Literature.
Moro E; Degli Esposti E; Borghese G; Manzara F; Zanello M; Raimondo D; Gava G; Arena A; Casadio P; Meriggiola MC; Seracchioli R
Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31480288
[No Abstract] [Full Text] [Related]
29. A pictorial review of ultrasonography of the FIGO classification for uterine leiomyomas.
Bajaj S; Gopal N; Clingan MJ; Bhatt S
Abdom Radiol (NY); 2022 Jan; 47(1):341-351. PubMed ID: 34581926
[TBL] [Abstract][Full Text] [Related]
30. Pregnancy-related changes in the size of uterine leiomyomas.
Neiger R; Sonek JD; Croom CS; Ventolini G
J Reprod Med; 2006 Sep; 51(9):671-4. PubMed ID: 17039693
[TBL] [Abstract][Full Text] [Related]
31. Incidental sonographic detection of bladder cancer in a woman with large uterine fibroids: significance and lessons learned.
Soliman MM; Cornman-Homonoff J; Schiffman MH
Clin Imaging; 2020 May; 61():1-3. PubMed ID: 31945687
[TBL] [Abstract][Full Text] [Related]
32. Development of a Model for the Prediction of Treatment Response of Uterine Leiomyomas after Uterine Artery Embolization.
Chung YJ; Kang SY; Chun HJ; Rha SE; Cho HH; Kim JH; Kim MR
Int J Med Sci; 2018; 15(14):1771-1777. PubMed ID: 30588202
[No Abstract] [Full Text] [Related]
33. Guideline No. 389-Medical Management of Symptomatic Uterine Leiomyomas - An Addendum.
Laberge PY; Murji A; Vilos GA; Allaire C; Leyland N; Singh SS
J Obstet Gynaecol Can; 2019 Oct; 41(10):1521-1524. PubMed ID: 31548041
[TBL] [Abstract][Full Text] [Related]
34. Spontaneous regression of a giant uterine leiomyoma after delivery: a case report and literature review.
Zhu-Ge L; Bei Q; Pan W; Ni X
BMC Pregnancy Childbirth; 2024 Feb; 24(1):123. PubMed ID: 38341545
[TBL] [Abstract][Full Text] [Related]
35. Stem cells and uterine leiomyomas: What is the evidence?
Carneiro MM
JBRA Assist Reprod; 2016 Mar; 20(1):33-7. PubMed ID: 27203304
[TBL] [Abstract][Full Text] [Related]
36. Vaginal Leiomyoma: A Case Report.
Shah M; Saha R; Kc N
JNMA J Nepal Med Assoc; 2021 May; 59(237):504-505. PubMed ID: 34508428
[TBL] [Abstract][Full Text] [Related]
37. ACR Appropriateness Criteria
; Knuttinen MG; Stark G; Hohenwalter EJ; Bradley LD; Braun AR; Gipson MG; Kim CY; Pinchot JW; Scheidt MJ; Sella DM; Weiss CR; Lorenz JM
J Am Coll Radiol; 2018 May; 15(5S):S160-S170. PubMed ID: 29724419
[TBL] [Abstract][Full Text] [Related]
38. Uterine Artery Embolization of Uterine Leiomyomas: Predictive MRI Features of Volumetric Response.
Kurban LAS; Metwally H; Abdullah M; Kerban A; Oulhaj A; Alkoteesh JA
AJR Am J Roentgenol; 2021 Apr; 216(4):967-974. PubMed ID: 33594913
[No Abstract] [Full Text] [Related]
39. CT findings after uterine artery embolization.
Vott S; Bonilla SM; Goodwin SC; Chen G; Wong GC; Lai A; Yegul T; DeLeon M
J Comput Assist Tomogr; 2000; 24(6):846-8. PubMed ID: 11105698
[TBL] [Abstract][Full Text] [Related]
40. CXCL12 Attracts Bone Marrow-Derived Cells to Uterine Leiomyomas.
Moridi I; Mamillapalli R; Kodaman PH; Habata S; Dang T; Taylor HS
Reprod Sci; 2020 Sep; 27(9):1724-1730. PubMed ID: 32020550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
